These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39271538)

  • 21. Tumor invasion in the central airway is a risk factor for early-onset checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.
    Moda M; Saito H; Kato T; Usui R; Kondo T; Nakahara Y; Murakami S; Yamamoto K; Yamada K
    Thorac Cancer; 2020 Dec; 11(12):3576-3584. PubMed ID: 33078531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer.
    Nishiyama O; Shimizu S; Haratani K; Isomoto K; Tanizaki J; Hayashi H; Yamazaki R; Oomori T; Nishikawa Y; Sano A; Nakagawa K; Tohda Y
    BMC Pulm Med; 2021 May; 21(1):155. PubMed ID: 33964920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case-control study.
    Kowalski B; Valaperti A; Bezel P; Steiner UC; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kohler M; Franzen D
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1711-1720. PubMed ID: 34347128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
    Suresh K; Voong KR; Shankar B; Forde PM; Ettinger DS; Marrone KA; Kelly RJ; Hann CL; Levy B; Feliciano JL; Brahmer JR; Feller-Kopman D; Lerner AD; Lee H; Yarmus L; D'Alessio F; Hales RK; Lin CT; Psoter KJ; Danoff SK; Naidoo J
    J Thorac Oncol; 2018 Dec; 13(12):1930-1939. PubMed ID: 30267842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the ratios of CD4/CD8 T-lymphocytes in the bronchoalveolar lavage fluid and lymph nodes in patients with sarcoidosis.
    Oda K; Ishimoto H; Yatera K; Yamada S; Nakao H; Ogoshi T; Noguchi S; Yamasaki K; Kawanami T; Mukae H
    Respir Investig; 2014 May; 52(3):179-83. PubMed ID: 24853018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased absolute number but not proportion of gamma/delta T-lymphocytes in the bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis.
    Tsao TC; Tsao KC; Lin MC; Huang CC; Yang CT; Liao SK; Chang KS
    Tuber Lung Dis; 1999; 79(4):215-20. PubMed ID: 10692989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.
    Tiu BC; Zubiri L; Iheke J; Pahalyants V; Theodosakis N; Ugwu-Dike P; Seo J; Tang K; Sise ME; Sullivan R; Naidoo J; Mooradian MJ; Semenov YR; Reynolds KL
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35705313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis.
    Schnabel A; Richter C; Bauerfeind S; Gross WL
    Thorax; 1997 Apr; 52(4):377-9. PubMed ID: 9196524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and chest CT features of immune checkpoint inhibitor-related pneumonitis].
    Zhang Q; Zhao SJ; Wang SH; Tao XL; Wu N
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):182-187. PubMed ID: 36781241
    [No Abstract]   [Full Text] [Related]  

  • 30. Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis.
    Lin X; Deng J; Deng H; Yang Y; Sun N; Zhou M; Qin Y; Xie X; Li S; Zhong N; Song Y; Zhou C
    Front Immunol; 2021; 12():818492. PubMed ID: 35095920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ and CD8+ T lymphocytes in lung tissue of NSIP: correlation with T lymphocytes in BALF.
    Qin L; Wang WZ; Liu HR; Xu WB; Qin MW; Zhang ZH; Xiao Y; Zhen WJ; Shi JH
    Respir Med; 2013 Jan; 107(1):120-7. PubMed ID: 23085212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Immune Checkpoint Inhibitor-Related Pneumonitis in Cancer Patients: A Systemic Review and Meta-Analysis.
    Zhou P; Zhao X; Wang G
    Respiration; 2022; 101(11):1035-1050. PubMed ID: 36108598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
    Drent M; Grutters JC; Mulder PG; van Velzen-Blad H; Wouters EF; van den Bosch JM
    Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):31-8. PubMed ID: 9186987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1 positive individuals.
    Bofill M; Lipman M; McLaughlin JE; Johnson MA; Poulter LW
    Eur Respir J; 1998 Mar; 11(3):548-53. PubMed ID: 9596100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
    Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
    Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between the incidence risk of pneumonitis and PD-1/PD-L1 inhibitors in advanced NSCLC: A meta-analysis of randomized controlled trials.
    Lin GF; Xu Y; Lin H; Yang DY; Chen L; Huang LL; Su XS; Xu YX; Zeng YM
    Int Immunopharmacol; 2021 Oct; 99():108011. PubMed ID: 34426108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate-induced pneumonitis: heterogeneity of bronchoalveolar lavage and differences between cancer and rheumatoid arthritis.
    D'Elia T
    Inflamm Allergy Drug Targets; 2014 Feb; 13(1):25-33. PubMed ID: 24372368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias.
    Papakosta D; Manika K; Kyriazis G; Kontakiotis T; Gioulekas D; Polyzoni T; Bouros D; Patakas D
    Respiration; 2009; 78(2):177-84. PubMed ID: 19246876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nomogram model for predicting the risk of checkpoint inhibitor-related pneumonitis for patients with advanced non-small-cell lung cancer.
    Zhang Y; Zhang L; Cao S; Wang Y; Ling X; Zhou Y; Zhong H
    Cancer Med; 2023 Aug; 12(15):15998-16010. PubMed ID: 37409360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.